Novel therapeutic strategies targeting myeloid-derived suppressor cell immunosuppressive mechanisms for cancer treatment
Cancer is the leading cause of death globally superseded only by cardiovascular diseases, and novel strategies to overcome therapeutic resistance against existing cancer treatments are urgently required. Myeloid-derived suppressor cells (MDSCs) are immature myeloid cells with potent immunosuppressiv...
Main Authors: | Eric Jou, Natasha Chaudhury, Fizza Nasim |
---|---|
Format: | Article |
Language: | English |
Published: |
Open Exploration Publishing Inc.
2024-02-01
|
Series: | Exploration of Targeted Anti-tumor Therapy |
Subjects: | |
Online Access: | https://www.explorationpub.com/Journals/etat/Article/1002212 |
Similar Items
-
Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies
by: Shifen Wang, et al.
Published: (2023-03-01) -
Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies
by: Vaishali Bhardwaj, et al.
Published: (2023-04-01) -
Myeloid-derived suppressor cells in gliomas
by: Anna Gieryng, et al.
Published: (2016-12-01) -
The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression
by: Viktor Umansky, et al.
Published: (2016-11-01) -
Myeloid-Derived Suppressor Cells in Solid Tumors
by: Tianmiao Ma, et al.
Published: (2022-01-01)